USA: The final results of the ANDES (Antithrombotic Therapy for the Prevention of Device-Related Thrombosis After Left Atrial ...
Please provide your email address to receive an email when new articles are posted on . The prevalence of left atrial thrombus is high in certain anticoagulated patients with atrial fibrillation, ...
(UPDATED) Device-related thrombus (DRT) following left atrial appendage (LAA) occlusion is associated with subsequent ischemic events, but a range of patient- and procedure-related factors may help ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
A new clinical trial published in the Journal of the American Medical Association found that intracardiac echocardiography ...
Testing of factor Xa inhibitors for the prevention of cardiovascular events in patients with rheumatic heart disease–associated atrial fibrillation has been limited. Of 4565 enrolled patients, 4531 ...
The role of direct oral anticoagulants as compared with vitamin K antagonists for atrial fibrillation after successful transcatheter aortic-valve replacement (TAVR) has not been well studied. We ...
IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback